BlackRock Portfolio holdings
AUM $5.23T
1-Year Return
24.48%
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
This Quarter Return
+3.39%
1 Year Return
+24.48%
3 Year Return
+103%
5 Year Return
+187.44%
10 Year Return
+430.33%
AUM
$1.87T
AUM Growth
+$64.2B
(+3.5%)
Cap. Flow
+$18.8B
Cap. Flow
% of AUM
1%
Top 10 Holdings %
Top 10 Hldgs %
12.67%
Holding
5,152
New
139
Increased
2,455
Reduced
1,941
Closed
154
Top Buys
| 1 |
DXC Technology
DXC
|
+$1.37B |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$1.1B |
| 3 |
NXP Semiconductors
NXPI
|
+$771M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$751M |
| 5 |
Altria Group
MO
|
+$668M |
Top Sells
| 1 |
YHOO
Yahoo Inc
YHOO
|
+$2.22B |
| 2 |
MJN
Mead Johnson Nutrition Company
MJN
|
+$1.02B |
| 3 |
CSC
Computer Sciences
CSC
|
+$901M |
| 4 |
WWAV
The WhiteWave Foods Company
WWAV
|
+$876M |
| 5 |
VAL
Valspar
VAL
|
+$746M |
Sector Composition
| 1 | Financials | 15.05% |
| 2 | Technology | 14.12% |
| 3 | Healthcare | 13.73% |
| 4 | Industrials | 10.15% |
| 5 | Consumer Discretionary | 9.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3926
Criteo
CRTO
$1.15B
| $351K | ﹤0.01% |
7,142
| – | – |
|
3927
Vanguard FTSE All-World ex-US ETF
VEU
$50.2B
| $350K | ﹤0.01% |
6,998
+682
| +11% | +$34.1K |
|
|
WSCI
3928
DELISTED
WSI Industries Inc
WSCI
| $349K | ﹤0.01% |
107,389
-4,205
| -4% | -$13.7K |
|
3929
United-Guardian
UG
$36.5M
| $336K | ﹤0.01% |
21,730
-640
| -3% | -$9.9K |
|
|
BCLI
3930
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
| $335K | ﹤0.01% |
5,384
+246
| +5% | +$15.3K |
|
3931
Achieve Life Sciences
ACHV
$144M
| $334K | ﹤0.01% |
422
-13
| -3% | -$10.3K |
|
|
BIOA
3932
DELISTED
BioAmber Inc.
BIOA
| $334K | ﹤0.01% |
130,043
-13,611
| -9% | -$35K |
|
|
KDMN
3933
DELISTED
Kadmon Holdings, Inc.
KDMN
| $332K | ﹤0.01% |
85,330
-190,077
| -69% | -$740K |
|
3934
Data I/O
DAIO
$30.1M
| $331K | ﹤0.01% |
41,683
+27,180
| +187% | +$216K |
|
3935
iShares Intermediate Government/Credit Bond ETF
GVI
$3.54B
| $330K | ﹤0.01% |
2,979
+808
| +37% | +$89.5K |
|
|
VIRX
3936
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| $328K | ﹤0.01% |
3,471
+1,113
| +47% | +$105K |
|
|
MNTX
3937
DELISTED
Manitex International, Inc.
MNTX
| $327K | ﹤0.01% |
46,792
+811
| +2% | +$5.67K |
|
3938
ICL Group
ICL
$7.92B
| $326K | ﹤0.01% |
68,850
+14,420
| +26% | +$68.3K |
|
|
STLY
3939
DELISTED
Stanley Furniture Co Inc
STLY
| $325K | ﹤0.01% |
284,881
-34,172
| -11% | -$39K |
|
3940
ING
ING
$74.6B
| $324K | ﹤0.01% |
18,630
+1,745
| +10% | +$30.3K |
|
|
VXRT
3941
DELISTED
Vaxart
VXRT
| $324K | ﹤0.01% |
43,994
-9,686
| -18% | -$71.3K |
|
|
LONE
3942
DELISTED
Lonestar Resources US Inc. Class A Common Stock
LONE
| $324K | ﹤0.01% |
+75,408
| New | +$324K |
|
|
TVIA
3943
DELISTED
TerraVia Holdings, Inc. Common Stock
TVIA
| $324K | ﹤0.01% |
1,389,544
-3,683,130
| -73% | -$859K |
|
|
IIN
3944
DELISTED
IntriCon Corporation
IIN
| $321K | ﹤0.01% |
39,179
+8,413
| +27% | +$68.9K |
|
|
TA
3945
DELISTED
TravelCenters of America LLC
TA
| $320K | ﹤0.01% |
15,641
-1,166
| -7% | -$23.9K |
|
3946
Blackstone
BX
$146B
| $319K | ﹤0.01% |
9,555
-269,944
| -97% | -$9.01M |
|
|
OIG
3947
DELISTED
Orbital Infrastructure Group, Inc. Common Stock
OIG
| $318K | ﹤0.01% |
2,066
-134
| -6% | -$20.6K |
|
|
RPRX
3948
DELISTED
Repros Therapeutics Inc.
RPRX
| $315K | ﹤0.01% |
685,127
-86,160
| -11% | -$39.6K |
|
|
GSB
3949
DELISTED
GlobalSCAPE, Inc.
GSB
| $314K | ﹤0.01% |
59,485
-34,405
| -37% | -$182K |
|
3950
Lantronix
LTRX
$187M
| $313K | ﹤0.01% |
129,034
+20,221
| +19% | +$49.1K |
|